Adefovir Dipivoxil-induced Osteomalacia: A Rare Case 
of Misdiagnosis due to Concurrent Thyroid Tumor

Yifan Zhang*; Kang Song; Ting Yin; Yan Xu

Adefovir Dipivoxil-induced Osteomalacia: A Rare Case of Misdiagnosis due to Concurrent Thyroid Tumor

Yifan Zhang*, Kang Song, Ting Yin, Yan Xu

Abstract

Background: Both the administration of adefovir dipivoxil and the elevation of primary parathyroid hormone can result in serum
electrolyte abnormalities and the development of metabolic bone disease. Adefovir dipivoxil-induced osteomalacia is a clinical disease that is
rarely seen and often leads to misdiagnosis. Case presentation: In this case, the patient developed osteomalacia due to renal tubular toxicity
caused by chronic use of adefovir dipivoxil. The drug indirectly affected the secretion of parathyroid hormone (PTH). Coincidentally, the patient also had a tumor below the thyroid, leading to a misdiagnosis. Conclusion: Osteomalacia caused by adefovir dipivoxil is a clinically rare
disease, and it is important not to overlook it as it may lead to misdiagnosis. Hence, in cases where laboratory tests reveal abnormal parathyroid hormone levels, it is crucial to inquire about the patients detailed medication history. This is applicable even in situations where there is
evidence suggesting primary hyperparathyroidism.

Keywords

Adefovir dipivoxil; Hyperparathyroidism; Osteomalacia; Case report

Full Text:

PDF

Included Database

References

[1] Dong X, Chen X, Tian Y, Wang J. Severe hypophosphataemic osteomalacia related to low-dose adefovir dipivoxil therapy in a hepatitis

B virus patient. Endokrynol Pol. 2021;72(2):181-182. doi: 10.5603/EP.a2021.0007. Epub 2021 Feb 23. PMID: 33619716.

[2] Xiang Q, Liu Z, Yu Y, Zhang H, Xie Q, Mu G, Zhang J, Cen X, Cui Y. Osteomalacia and renal failure due to Fanconi syndrome caused

by long-term low-dose Adefovir Dipivoxil: a case report. BMC Pharmacol Toxicol. 2020 Jun 5;21(1):43. doi: 10.1186/s40360-020-

00421-6. PMID: 32503675; PMCID: PMC7275610.

[3] Tang W, Jia H, Wang B, Chai Y, Liu T, Wang H, Dai C. Evaluating distal renal tubular acidification function in primary hyperparathy-roidism and its effects on bone mineral density. BMC Musculoskelet Disord. 2021 Jan 12;22(1):69. doi: 10.1186/s12891-021-03954-x.

PMID: 33435934; PMCID: PMC7805182.

[4] Sun L, Yi D, Sun W, Wang C. Retrospective analysis of the clinical characteristics of adefovir dipivoxil-induced Fanconis syndrome in

the Chinese population. J Clin Pharm Ther. 2020 Aug;45(4):722-728. doi: 10.1111/jcpt.13154. Epub 2020 May 14. PMID: 32406123.

[5] Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101247. doi:

10.1016/j.beem.2018.09.013. Epub 2018 Sep 28. PMID: 30477754..

[6] Srisuwarn P, Disthabanchong S. Role of Parathyroid Hormone and Parathyroid Hormone-Related Protein in Protein-Energy Malnutrition. Front Biosci (Landmark Ed). 2023 Aug 15;28(8):167. doi: 10.31083/j.fbl2808167. PMID: 37664938.

[7] Bandgar T, Shah N. Revisiting hypophosphatemic rickets/osteomalacia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101859.

doi: 10.1016/j.beem.2024.101859. Epub 2024 Jan 6. PMID: 38238129.

Refbacks

There are currently no refbacks.